CORPORATE

CORPORATE
PROFILE

Company NameMetcela Inc.
FoundedMarch 9, 2016
Outline of BusinessResearch and development of fibroblast-based therapies for cardiac diseases

ACCESS

LIC Lab/Office

Life Innovation Center 3-25-22Tonomachi, Kawasaki-ku,Kawasaki-shi, Kanagawa 210-0821


iCONM Lab/Office

3-25-14Tonomachi,Kawasaki-ku,Kawasaki-shi, Kanagawa 210-0821

HISTORY

2014
Launched Project Metcela

2016.03
Incorporated Metcela Inc.

2016.06
Chosen for STS grant (JPY 70M) from NEDO

2017.03
Chosen for SCA grant (JPY 70M) from NEDO

2017.04
Initiated joint research with University of Tsukuba

2018.07
Chosen for Hashiwatashi grant from NEDO

2018.09
Raised $4.6 Million in Series A Financing Round

2019.06
Selected for J-Startup 2019, a government-led initiative for supporting startups

2020.06
Signed a business partnership agreement with Japan Lifeline

2021.01
Secured $12.7 Million in Series B Financing Round

2021.07
Initiated Phase I clinical trial for chronic ischemic heart failure

2022.04
Acquired Japan Regenerative Medicine